Results
3049
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3049 companies
Dx & Vx
Market Cap: ₩119.6b
Engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea.
A180400
₩2,455.00
7D
-4.5%
1Y
-25.6%
Hunan Jingfeng PharmaceuticalLtd
Market Cap: CN¥5.1b
Manufactures and sells chemical drugs and biological agents in China.
000908
CN¥5.77
7D
4.9%
1Y
32.9%
ChoA Pharmaceutical
Market Cap: ₩39.3b
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea.
A034940
₩1,234.00
7D
10.2%
1Y
-9.9%
Enzychem Lifesciences
Market Cap: ₩86.6b
Engages in developing novel small molecule therapeutics for patients with unmet needs for oncology, inflammatory, and severe respiratory diseases in South Korea.
A183490
₩1,129.00
7D
5.1%
1Y
-22.5%
Nxera Pharma
Market Cap: JP¥90.3b
Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.
4565
JP¥974.00
7D
1.0%
1Y
-24.6%
Mirxes Holding
Market Cap: HK$11.1b
A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.
2629
HK$44.28
7D
-1.2%
1Y
n/a
PaxMedica
Market Cap: US$25.2k
A clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms.
PXMD
US$0.0002
7D
0%
1Y
-99.8%
Argent BioPharma
Market Cap: AU$8.3m
A clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally.
RGT
AU$0.10
7D
-25.0%
1Y
-67.7%
Zhejiang Taimei Medical Technology
Market Cap: HK$2.6b
Zhejiang Taimei Medical Technology Co., Ltd.
2576
HK$4.55
7D
-7.1%
1Y
n/a
Red White & Bloom Brands
Market Cap: CA$16.5m
Manufactures, processes, and distributes cannabis products and accessories in the United States, Canada, and international territories.
RWB
CA$0.035
7D
0%
1Y
-50.0%
ANG Lifesciences India
Market Cap: ₹369.8m
Manufactures and sells pharmaceuticals products and formulations in India.
540694
₹29.64
7D
17.3%
1Y
-52.8%
BF Biosciences
Market Cap: PK₨14.6b
A diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products.
BFBIO
PK₨166.23
7D
-2.5%
1Y
n/a
Indofarma
Market Cap: Rp390.5b
Manufactures and sells pharmaceutical products in Indonesia and internationally.
INAF
Rp126.00
7D
0%
1Y
-74.3%
Maverick Lifestyle
Market Cap: US$45.4m
Engages in the manufacture, branding, marketing, distribution, and sale of products infused with hemp-derived cannabinoids in the United States.
MVRK
US$4.75
7D
n/a
1Y
n/a
MYND Life Sciences
Market Cap: CA$5.2m
A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.
MYND
CA$0.07
7D
0%
1Y
n/a
Cannabis Bioscience International Holdings
Market Cap: US$6.8m
Cannabis Bioscience International Holdings, Inc.
CBIH
US$0.0006
7D
-1.6%
1Y
-14.3%
Impact BioMedical
Market Cap: US$7.8m
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.
IBO
US$0.64
7D
7.4%
1Y
n/a
Real Brands
Market Cap: US$269.9k
Produces and sells hemp cannabinoids oil and related products.
RLBD
US$0.0001
7D
9,900.0%
1Y
-98.7%
Aspire Biopharma Holdings
Market Cap: US$21.3m
An early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States.
ASBP
US$0.43
7D
-25.2%
1Y
-96.2%
Bio-Thera Solutions
Market Cap: CN¥12.8b
A biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally.
688177
CN¥30.83
7D
-9.2%
1Y
53.2%
Chiome Bioscience
Market Cap: JP¥9.4b
Engages in the research and development of drug discovery technology platforms worldwide.
4583
JP¥134.00
7D
-2.9%
1Y
10.7%
WOOJUNG BIO
Market Cap: ₩29.7b
Provides non-clinical research agency services.
A215380
₩1,754.00
7D
4.1%
1Y
-29.6%
GC Cell
Market Cap: ₩298.9b
Develops cell therapy products.
A144510
₩19,910.00
7D
4.5%
1Y
-36.7%
Tus-Pharmaceutical Group
Market Cap: CN¥2.9b
Manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China.
000590
CN¥12.00
7D
2.5%
1Y
130.3%
China NT Pharma Group
Market Cap: HK$802.4m
An investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China.
1011
HK$1.21
7D
34.4%
1Y
404.2%
Jacobio Pharmaceuticals Group
Market Cap: HK$9.1b
An investment holding company, engages in the in-house discovery and development of oncology therapies.
1167
HK$10.85
7D
3.1%
1Y
545.8%
NKMAX
Market Cap: ₩172.7b
Manufactures and sells biological products in South Korea.
A182400
₩2,020.00
7D
0%
1Y
-69.5%
Estrella Immunopharma
Market Cap: US$38.2m
A clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
ESLA
US$1.03
7D
-3.7%
1Y
3.0%
Deva Holding
Market Cap: ₺12.9b
Manufactures, markets, and sells pharmaceutical products in Turkey.
DEVA
₺64.30
7D
-3.8%
1Y
-3.5%
Kaya Holdings
Market Cap: US$831.3k
A vertically integrated legal cannabis enterprise, operates psychedelic treatment clinics and medical cannabis dispensaries in the United States.
KAYS
US$0.02
7D
53.8%
1Y
-56.7%
Emmaus Life Sciences
Market Cap: US$734.5k
A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.
EMMA
US$0.011
7D
-8.0%
1Y
475.0%
Bespoke Extracts
Market Cap: US$2.7m
Together with its subsidiary, Bespoke Extracts Colorado, LLC, produces and sells pre-rolled marijuana cigarettes in the United States.
BSPK
US$0.24
7D
23.1%
1Y
152.6%
XTL Biopharmaceuticals
Market Cap: ₪38.8m
A biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel.
XTLB
₪0.044
7D
4.8%
1Y
-55.6%
Pharmagreen Biotech
Market Cap: US$663.6k
Operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America.
PHBI
US$0.001
7D
-9.1%
1Y
-25.9%
Allied
Market Cap: US$1.3m
A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.
ALID
US$0.011
7D
0%
1Y
-87.5%
Vectus Biosystems
Market Cap: AU$3.9m
Engages in the medical research and development activities in Australia.
VBS
AU$0.073
7D
0%
1Y
-8.8%